investment · Logistics
Nigerian Cold Chain Equipment Financing — Pharmaceutical and Food Distribution Fleet
- Location
- Lagos, NG
- Value
- $800,000 – $3,500,000
- Deadline
- 28 Jan 2027
- Urgency
- medium
Requirement
Nigeria loses an estimated 40% of pharmaceutical products and 30-45% of food produce to spoilage annually — largely attributable to an underdeveloped cold chain infrastructure that serves less than 15% of the country's storage and distribution needs. The NAFDAC cold chain assessment of 2024 identified a fleet financing gap of $800M–$3.5B for refrigerated trucks, cold storage units, and temperature-controlled last-mile vehicles required to meet WHO Good Distribution Practice standards for pharmaceuticals alone. This opportunity structures asset-based equipment financing for a verified Nigerian cold chain operator seeking $800K–$3.5M to expand its refrigerated fleet servicing pharmaceutical distributors and premium food processors in Lagos, Abuja, and Port Harcourt. The borrower holds NAFDAC distribution certification, has existing contracts with three tier-1 pharmaceutical companies, and generates consistent monthly revenue from logistics service fees. Equipment serves as primary collateral; receivables from pharmaceutical clients provide secondary security. The ideal lender is an asset-based financing institution, development finance entity, or private credit fund with Nigeria or West Africa operations. Experience in pharmaceutical distribution or food supply chain preferred. The borrower is verified at Enhanced tier; lenders access full financial documentation — three years of audited accounts, client contracts, and NAFDAC certification — within the deal room. AfroSynergy structures this through the Equipment Financing template with 100% escrow on disbursement. Milestone-based drawdown: 40% on first equipment delivery, 40% on second tranche, 20% on operational certification. Full asset register and insurance documentation maintained in the deal room. Nigeria's pharmaceutical manufacturing ambitions under the AfCFTA Pharmaceutical Manufacturing Plan create direct demand growth for compliant cold chain distribution. WHO pre-qualification of two Nigerian manufacturers in 2025 has opened export corridors that require cold chain documentation — making this financing directly AfCFTA-relevant and time-sensitive for the 2026 export season. Express interest to access the verified borrower's financial documentation and fleet expansion plan.
Connect with this counterparty
The counterparty’s verified identity, verification tier, supporting documents and contact route open once you have an account. Every party on AfroSynergy is verified before a deal room opens.